Amerikanische Gesellschaft für Hirudotherapie

Exploring the Therapeutic Potential: Ta'līq al-'Alaq (Leech Therapy) for Qarha Khabītha (Non-Healing Ulcer): A Case Study

Begum S, Fareed R, Shoaib M, Sultana A (2025) · Alternative Therapies in Health and Medicine · n=1

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidenceCondition: Venous Leg Ulcer
Sample size of this trial compared with other Venous Leg Ulcer trialsBegum S 20251Bopparathi S 20231
This trial (highlighted) by sample size alongside other indexed Venous Leg Ulcer trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-patient Unani-medicine case report of bilateral chronic non-healing lower-extremity ulcers (27-year duration) treated with weekly Ta'liq al-Alaq (leech therapy) over 6 weeks (Indian Unani medicine institutional context)
Sample size (n)
1
Intervention
Weekly hirudotherapy (Ta'liq al-Alaq) sessions for 6 weeks, applied to three non-healing ulcers on bilateral lower extremities; Unani principle of Istifragh (expulsion of morbid humours)
Comparator
Not applicable - single case report; historical conventional wound care had failed for 27 years before leech therapy
Primary endpoint
Wound healing parameters (size, discharge, smell, pain, edge morphology, wound floor) at 2, 4, and 6 weeks
Primary result
Two of three ulcers completely healed at 6 weeks; third ulcer showed partial healing; authors report substantial improvement in pain, discharge, and wound edge morphology; case framed as cost-effective alternative when conventional methods fail
Follow-up duration
6 weeks

Key Findings

  • Weekly leech sessions for 6 weeks produced complete healing in 2/3 chronic ulcers and partial healing in the third
  • Patient had failed 27 years of conventional care prior to leech therapy
  • Authors highlight Unani Istifragh principle (expulsion of morbid humours) as the conceptual framework
  • Pain, discharge, and wound morphology all improved
  • Adds Indian Unani-medicine geography to the leech-venous-ulcer literature

Limitations

  • Single case (n=1) - cannot generalize
  • No blinded outcome adjudication
  • 27-year ulcer duration with prior conventional-care failure introduces regression-to-the-mean / unusual responder bias
  • Concurrent adjuvant Unani modalities may have contributed to outcomes
  • No biochemical or microbiological wound markers

Clinical Implications

Begum 2025 is a hypothesis-generating case report that adds Unani-medicine geographic and methodological context to the small leech-therapy venous-ulcer literature. For US clinicians, the case does not directly support practice changes but reinforces the need for properly powered RCTs in this indication. For Indian and South Asian Unani-medicine integration, the case adds to the published wound-healing leech literature relevant to traditional-medicine practice contexts.

Related Trials

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.